Physician profile
Kevin P Mclaughlin
NPI 1881656288
$1,032.42
in general payments reported to CMS, 2019-2025
18 companies · $64.34 in 2025
The $64.34 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $160 · 2021: $272 · 2022: $163 · 2023: $39.10 · 2025: $64.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $100 · Education: $3.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.42 |
| Education | $3.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $437.04 | 2019-2022 | |
| Abbvie INC. | $106.74 | 2019-2022 | |
| Boston Scientific Corporation | $103.85 | 2019-2023 | Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit |
| C. R. Bard, INC. & Subsidiaries | $61.32 | 2025 | Bard Urinary Drainage Bag |
| Pfizer INC. | $40.97 | 2019 | |
| Antares Pharma, INC. | $37.04 | 2019-2021 | |
| Urovant Sciences INC | $33.84 | 2022 | |
| Janssen Biotech, INC. | $28.10 | 2022 | |
| Blue Earth Diagnostics | $27.67 | 2021 | |
| Axonics, INC. | $25.30 | 2020 | |
| Ambu INC. | $20.93 | 2020-2022 | |
| Rochester Medical Corporation | $20.16 | 2021 | |
| Travere Therapeutics, INC. | $18.13 | 2020-2025 | Thiola |
| Ferring Pharmaceuticals INC. | $17.59 | 2019 | |
| Ethicon US, LLC | $15.32 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $13.56 | 2021 | |
| Myovant Sciences INC. | $12.61 | 2022 | |
| Coloplast Corp | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mclaughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.